Sylvamo’s Q2 Earnings Call: European Exit Timing and Price Realization Signals Don’t Match
Date of Call: Aug 7, 2026
Guidance:
- Expect better earnings across most key drivers in the second half of the year.
- Expect a $75M to $85M benefit from better price and mix in the second half compared to the first half.
- In North America, expect seasonally higher demand in the second half; in Europe, supply and demand remain stable.
- Plan maintenance outages will be unfavorable by ~$5M in Q3.
- Input and transportation costs expected to be favorable in H2 due to lower fiber costs offsetting energy/chemicals/transportation increases.
- Overall, expect much better earnings performance for the last six months of the year.
Business Commentary:
Earnings Performance and Cost Management:
- Sylvamo reported a
$75 million to $85 millionbenefit from better price and mix in the second half compared to the first half. - This improvement is due to realized paper price increases across regions, favorable lower fiber costs in Latin America and Europe, and operational efficiencies.
Strategic Investments and Capacity Expansion:
- The company expects
$50 millionannual benefits from the paper machine speed-up and new sheeter projects, with about$30 to $40 millionrealized in 2027. - These investments are aimed at increasing capacity, improving mix and efficiency, and enhancing customer service.
European Operations and Cost Reduction:
- Sylvamo is targeting cost reductions in Europe, aiming for significant improvements to make operations cash positive on a mid-cycle basis.
- The company is focused on strategic execution, including productivity improvements and cost reductions, with a potential review of options by 2027 if performance targets are not met.
North American Market Dynamics:
- North American industry supply was reduced by
7%annually due to the conversion of the Riverdale Mill, impacting volume dynamics. - The company is realizing paper price increases and expects seasonally higher demand in the second half, supported by improved supply and demand dynamics.
Sentiment Analysis:
Overall Tone: Positive
- "We expect better earnings across most of our key drivers this slide provides some staff Price and mix should have a significant improvement perspective to how we see the second half of the year as compared to the first... We expect to have $75 million to $85 million benefit from better price and mix compared to the first half... In total, we expect a much better earnings performance for the last six months of the year."
Q&A:
- Question from Daniel Herriman (Citodi): In North America, margin was up at 15%. This is maybe lower sourcing costs from bringing product in from Brazil. With most of the free cash flow for the year expected in the other than Europe. And then leverage finished the quarter at 2.2 back half. Can you give us a better idea of how much of the first half working capital build reverses and where you expect to end the year on leverage?
Response: Working capital build will mostly unwind by year-end, with about 50,000 tons of inventory in North America expected to be drawn down in the second half. North America margin improvement was largely due to price/mix and lower operations costs.
- Question from Matthew McKellar (RBC Capital Markets): I've understood your comments on slide eight correctly. Is that sales? It sounds like you're expecting lower North American volumes in the second half of the year. Volumes or production? And can I ask what the bogey might be for North American volumes at this point?
Response: Lower North American volumes in H2 are due to the loss of Riverdale Mill supply (~90k tons), the Eastover mill outage being longer than planned, and bringing in less volume from Europe/Brazil due to tariffs. The net impact of Riverdale and the paper machine speed-up will be a reduction.
- Question from Matthew McKellar (RBC Capital Markets): It sounds like you have pricing as a tailwind across each segment into Q3. Could you maybe spend a minute just running through what should trend sequentially by region, either on average or as yet? Price is currently announced that pending in the markets. Maybe talk about how price affects Q3 in comparison to where you were in Q2.
Response: Pricing benefits (70% of the $75-85M H2 improvement) are flowing through in Q3, with a third European price increase being implemented in July. Prices should be relatively flat and carry into Q4.
- Question from Mike Oxland (Truist Securities): Regarding the EU, what happened and what's happening with your European operations... any call you have on your European operations and your plans there?
Response: European operations are ahead of plan at SIOT mill, with focus on cost reduction and productivity. If outlook remains unsatisfactory, options (including sale/shutdown) may be considered by 2027, with a target cost reduction of over $50M.
- Question from Mike Oxland (Truist Securities): You guys mentioned $75 million to $85 million from better price mix in the second half over the first half. Any way to help quantify the benefit from better volumes, better opt-in costs, better input costs? Any way to quantify that in the second half versus the first half? And the second question, the poison pill ends in November. What's your plan regarding the poison pill?
Response: No specific guidance provided for volume/ops/input cost benefits due to uncertainty. The poison pill plan remains in place; a board decision on its renewal will be addressed at the September meeting.
- Question from George L. Stavos (BofA Securities): We appreciate you actually providing the pricing guidance... Did I correctly summarize that, or what would you do to modify add correct to what I just relayed?
Response: Pricing benefits will flow more evenly between Q3 and Q4, with slightly more in Q4. By Q4, pricing will be at a full run rate across all regions.
- Question from George L. Stavos (BofA Securities): We noticed the tax rate moved up a little bit in terms of your guide. You know, that can be a lot of different things. It's probably mixed, but could you help us understand why the effective rate?
Response: The higher tax rate is due to a $9M expense related to a $30M VAT credit valuation allowance in Brazil, from changes in VAT rules. No change in mix or ongoing profitability.
- Question from Matthew McKellar (RBC Capital Markets): Just one more for me. I thought slide 12 was pretty interesting. As I think about the more kind of operational focus items there, operational excellence, cost leadership, and maybe to some degree customer centricity, $300 million free cash flow.
Response: Achieving the $300M+ free cash flow target depends largely on cost leadership (improving cost reduction rate) and customer centricity (ensuring intense customer service in all regions).
- Question from Mike Oxland (Truist Securities): First, can you talk about the impact on the U.S. market from additional Canadian tariffs? Second question, why is backward integration necessary in Brazil?
Response: The Canadian tariffs impact is minimal due to low import volume. Backward integration in Brazil is necessary due to low-cost wood and the ability to produce low-cost energy, making it the lowest-cost, highest cash-generating mill.
- Question from George L. Stavos (BofA Securities): Last two for me, one on Europe and one on the bridge into third quarter. So for Europe guys, you might have missed it, but have you quantified what benefit you're getting. Can you... from Improved Fiber in Numola... what kind of benefit on fiber you expect to get in Numola?... And the bridge.
Response: Fiber costs at Numola have decreased ~20% since peak, with benefits starting to be seen in Q3. Regarding the bridge to Q3, the impact of lower fiber costs is beginning to flow through, and there is an additional ~$9-10M impact from reduced Brazilian volume shipments due to tariffs in the second half.
Contradiction Point 1
North American Mix Impact
Contradiction on whether the unfavorable mix impact will persist into the next quarter.
What were Daniel Herriman's comments on Citodic's earnings call? - Daniel Herriman (Citodic)
2026Q2: The inventory build-up ... will largely unwind in the second half of the year." and "North American volumes will be lower in H2 due to the permanent loss of Riverdale supply... - Don Sylvamo and John Sims.
Can you provide more details on the factors driving the North America margin improvement from 10% in Q1 to 15% in Q2, specifically the contribution from price/mix, as well as the working capital reversal and expected leverage at year-end? - Nicolo Buccioni (Truist Securities, for Michael Roxland)
2026Q1: [The inventory build for Eastover and Riverdale transition will continue in Q2, making the mix impact similar to Q1.] - Don Devlin.
Contradiction Point 2
European Strategic Review
Contradiction on the timeline for a potential decision on European asset sales or closures.
Mike Oxland (Truist Securities) - Mike Oxland (Truist Securities)
2026Q2: A decision on the strategic review ... could be made in 2027. - John Sims.
What is the update on the European strategic review, including the timeline for a decision, available options, the quantified H2 benefit from improved volumes and input costs, and comments on the poison pill? - George Staphos (Bank of America Securities) – Follow-up:
2026Q1: [The company] continuously evaluates its portfolio. Currently, they are committed to improving Europe's performance through the outlined strategy and leadership. They have not decided to divest. - John Sims, Don Devlin.
Contradiction Point 3
Timing of Price/Margin Benefit Realization in Europe
Contradiction on when price increases will start contributing to margins.
What are your thoughts on the company's Q4 earnings? - Matthew McKellar (RBC Capital Markets)
2026Q2: Pricing benefits (70% of the $75–$85 million H2 improvement) are flowing through in Q3, with a third European price increase being implemented in July. - John Sims(CFO)
What is the bogey, and can you detail Q3 pricing trends by region and explain the fiber cost benefits in the back half? - Daniel Harriman (Sidoti & Company, LLC)
2025Q4: Margin improvement will require market improvement and announced price increases, which will begin to be realized in Q2 2026, not Q1. - John Sims(CFO)
Contradiction Point 4
Strategic Outlook and Financial Target for European Operations
Contradiction on the strategic focus and financial target for the European business.
Mike Oxland (Truist Securities) - Mike Oxland (Truist Securities)
2026Q2: European performance has improved since management changes last year, but conditions remain difficult. A decision on the strategic review (including potential asset sales or closures) could be made in 2027. The company is targeting cost reductions of significantly above $50 million annually in Europe to make the operations cash positive. - John Sims(CFO)
Can you provide an update on the European strategic review, including the potential decision timeline, options, the quantified H2 benefits from improved volumes and input costs, and comments on the poison pill? - George Staphos (BofA Securities)
2025Q4: Europe has always been a strategic bet. ... Nymolla’s fit is strong due to its sole focus on uncoated freesheet, good cost position (when wood costs normalize), and attractive mix... - John Sims(CFO)
Contradiction Point 5
Cost Position and Strategic Fit of the Nymolla (Numola) Mill
Contradiction on the mill's cost competitiveness and strategic importance.
George L. Stavos (BofA Securities) – Follow-up - George L. Stavos (BofA Securities) – Follow-up
2026Q2: The benefit from the 20% wood cost decrease will start appearing in Q3 and carry through the year. ... The company is targeting cost reductions of significantly above $50 million annually in Europe to make the operations cash positive. - John Sims(CFO)
How does the fiber cost benefit at Numola and the European pulp market impact Q3 earnings expectations? - George Staphos (BofA Securities)
2025Q4: Nymolla’s challenges stem from a longer, deeper downturn than expected and higher-than-anticipated wood costs. However, wood costs are now starting to ease... Nymolla’s fit is strong due to... good cost position (when wood costs normalize)... - John Sims(CFO)
<<Discover what executives don't want to reveal in conference calls
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.



Comments
No comments yet